Zalgen Labs is a biotechnology company specializing in the production of biological molecules targeting human infectious diseases. It uses its proprietary mammalian cell-based biomanufacturing system CHOLCelect in order to deliver biologicals. The company is engaged in the distribution of Lassa virus reagents, nucleoprotein and glycoprotein antigens, antibodies, hemorrhagic fever test kits, etc.